Related Experiment Video
Updated: May 15, 2025

06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.5K
ATM Kinase Small Molecule Inhibitors Prevent Radiation-Induced Apoptosis of Mouse Neurons In Vivo
Yüksel Aydar1, Sanara S Rambukkanage2, Lauryn Brown2
1Department of Anatomy, Medical School of Osmangazi University, Eskisehir 26040, Turkiye.
Summary
Small molecule ATM inhibitors (ATMi) do not increase radiation toxicity in healthy brain tissue. In fact, ATMi may protect neurons from radiation-induced apoptosis, suggesting a potential neuroprotective role in cancer therapy.
Area of Science:
- Neuroscience
- Oncology
- Radiotherapy
Background:
- ATM kinase is a therapeutic target for tumor radiosensitization.
- Radiation can cause neuro-inflammation and neurodegeneration.
- Effects of ATM inhibitors (ATMi) on healthy brain tissue are largely unknown.
Purpose of the Study:
- To investigate the impact of ATMi combined with radiation on the central nervous system (CNS), specifically focusing on neuronal fate.
- To assess DNA damage response (DDR) and apoptosis in neurons following ATMi and radiation treatment.
Main Methods:
- In vivo studies using mice.
- Immunostaining techniques to assess neuronal viability, degeneration, and apoptosis.
- Multiplex immunostaining to evaluate the effect of a clinical candidate ATMi (AZD1390).
Main Results:
- Radiation alone significantly decreased viable neurons and increased neuronal degeneration and apoptosis.
- ATMi alone had minimal impact on neuron viability or apoptosis.
- ATMi did not exacerbate radiation-induced toxicity.
- AZD1390 protected mouse neurons from apoptosis by 90% at 4 hours post-radiation.
Conclusions:
- ATM kinase inhibition with small molecules does not increase neuronal radiation toxicity.
- ATM inhibition may offer short-term protection against radiation-induced neuronal apoptosis.
- Transient ATM blockade might be protective due to a normal ATM-p53 response.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
The Intrinsic Apoptotic Pathway
5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K

